<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174185</url>
  </required_header>
  <id_info>
    <org_study_id>01-18-530605</org_study_id>
    <nct_id>NCT02174185</nct_id>
  </id_info>
  <brief_title>Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders</brief_title>
  <official_title>A Prospective and Comparative Study of Health-related Quality of Life (HRQoL) in Patients With Conduit Diversion or Orthotopic Neobladder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the health-related quality of life (HRQoL) between
      patients underwent conduit diversion and orthotopic neobladder after radical cystectomy. The
      investigators plan to use validated HRQoL questionnaires to learn about how the different
      urinary diversion operations affect the HRQoL of people living with bladder cancer. The
      findings from this study may help doctors and patients choosing the proper operation type.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in HRQoL of bladder cancer patients with different types of urinary diversions</measure>
    <time_frame>Preoperative baseline and 3, 6, 12, 18 months postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score differences between the two groups of patients in the relevant domains from three various validated tools of HRQoL</measure>
    <time_frame>Preoperative baseline and 3, 6, 12, 18 months postoperatively</time_frame>
    <description>The aim is to compare three various validated tools of HRQoL to study their relative contributions in accounting for variance in prediction of patient HRQoL.
The three validated tools of HRQoL are EORTC-QLQ-C30/BLM (The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire/bladder cancer module), FACT-BL (Functional Assessment of Cancer Therapy-Bladder cancer) and BCI (Bladder Cancer Index).
The two groups are conduit diversion group and orthotopic neobladder group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score changes of each patient group during the follow-up</measure>
    <time_frame>Preoperative baseline and 3, 6, 12, 18 months postoperatively</time_frame>
    <description>Longitudinally learn about the changes of each individual patient HRQoL after urinary diversion and compare the changes of two groups, i.e. conduit diversion group and orthotopic neobladder group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective examination outcomes</measure>
    <time_frame>Preoperative baseline and 3, 6, 12, 18 months postoperatively</time_frame>
    <description>Supplement the assessment by interviewing the patients with some lab and image examinations, such as renal function tests, liver function tests, urine culture, urine cytology, chest radiography, ultrasound of kidney, ureter and bladder (KUB) etc.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>bladder cancer, conduit diversion</arm_group_label>
    <description>new patients with bladder cancer scheduled for radical cystectomy and subsequent conduit diversion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bladder cancer, orthotopic neobladder</arm_group_label>
    <description>new patients with bladder cancer scheduled for radical cystectomy and subsequent orthotopic neobladder</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>validated health-related quality of life questionnaires</intervention_name>
    <description>All eligible patients who agree to participate will be asked to fulfill three different validated health-related quality of life questionnaires (EORTC-QLQ-C30/BLM, FACT-BL and BCI) prior to surgery and at 3, 6, 12, 18 months postoperatively.</description>
    <arm_group_label>bladder cancer, conduit diversion</arm_group_label>
    <arm_group_label>bladder cancer, orthotopic neobladder</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All eligible patients in Wuhan Union Hospital, Huazhong University of Science and
        Technology.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of muscle invasive bladder cancer

          -  Must be scheduled for radical cystectomy and subsequent conduit diversion or
             orthotopic neobladder

          -  Must be able to provide informed consent

          -  Must be 18 years of age or older

          -  May have had received intravesical neoadjuvant, adjuvant chemotherapy or immunotherapy

        Exclusion Criteria:

          -  Follow-up data not obtained at Wuhan Union Hospital
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaoping Zhang, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Urology, Wuhan Union Hospital, Huazhong University of Science and Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hangchuan Shi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Urology, Wuhan Union Hospital, Huazhong University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaoping Zhang, MD, PhD</last_name>
    <phone>86 27 85351625</phone>
    <email>xzhang@hust.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hangchuan Shi, MD</last_name>
    <phone>86 13098893958</phone>
    <email>hangchuan_shi@hust.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Urology, Wuhan Union Hospital, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoping Zhang, MD, PhD</last_name>
      <phone>86 27 85351625</phone>
      <email>xzhang@hust.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Hangchuan Shi, MD</last_name>
      <phone>86 13098893958</phone>
      <email>hangchuan_shi@hust.edu.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Xiaoping Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hangchuan Shi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiang Li, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2014</study_first_posted>
  <last_update_submitted>August 1, 2014</last_update_submitted>
  <last_update_submitted_qc>August 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Zhang Xiaoping</investigator_full_name>
    <investigator_title>Director of Department of Urology, Wuhan Union Hospital, HUST</investigator_title>
  </responsible_party>
  <keyword>bladder cancer</keyword>
  <keyword>conduit diversion</keyword>
  <keyword>orthotopic neobladder</keyword>
  <keyword>health-related quality of life</keyword>
  <keyword>validated questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

